Literature DB >> 16890187

Sphingosine 1-phosphate regulates cytoskeleton dynamics: implications in its biological response.

Chiara Donati1, Paola Bruni.   

Abstract

The bioactive sphingolipid sphingosine 1-phosphate (S1P) elicits robust cytoskeletal rearrangement in a large variety of cell systems, mainly acting through a panel of specific cell surface receptors, named S1P receptors. Recent studies have begun to delineate the molecular mechanisms involved in the complex process responsible for cytoskeletal rearrangement following S1P ligation to its receptors. Notably, changes of cell shape and/or motility induced by S1P via cytoskeletal remodelling are functional to the biological action exerted by S1P which appears to be highly cell-specific. This review focuses on the current knowledge of the regulatory mechanisms of cytoskeleton dynamics elicited by S1P, with special emphasis on the relationship between cytoskeletal remodelling and the biological effects evoked by the sphingolipid in various cell types.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16890187     DOI: 10.1016/j.bbamem.2006.06.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

1.  S1P₂ receptor regulation of sphingosine-1-phosphate effects on conventional outflow physiology.

Authors:  Grant M Sumida; W Daniel Stamer
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

2.  Sphingosine 1-phosphate differentially regulates proliferation of C2C12 reserve cells and myoblasts.

Authors:  Elena Rapizzi; Chiara Donati; Francesca Cencetti; Paola Nincheri; Paola Bruni
Journal:  Mol Cell Biochem       Date:  2008-05-03       Impact factor: 3.396

3.  Molecular mechanisms of biogenesis of apoptotic exosome-like vesicles and their roles as damage-associated molecular patterns.

Authors:  Soo Jeong Park; Jeong Mi Kim; Jihyo Kim; Jaehark Hur; Sun Park; Kyongmin Kim; Ho-Joon Shin; Yong-Joon Chwae
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-21       Impact factor: 11.205

4.  Sphingosine-1-phosphate enhancement of cortical actomyosin organization in cultured human Schlemm's canal endothelial cell monolayers.

Authors:  Grant M Sumida; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-30       Impact factor: 4.799

Review 5.  Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress.

Authors:  Joel S Karliner
Journal:  Biochim Biophys Acta       Date:  2012-06-23

Review 6.  Extracellular and intracellular actions of sphingosine-1-phosphate.

Authors:  Graham M Strub; Michael Maceyka; Nitai C Hait; Sheldon Milstien; Sarah Spiegel
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

7.  Differential elastic responses to barrier-altering agonists in two types of human lung endothelium.

Authors:  P Viswanathan; Y Ephstein; J G N Garcia; M Cho; S M Dudek
Journal:  Biochem Biophys Res Commun       Date:  2016-07-27       Impact factor: 3.575

8.  Protein kinase C-epsilon regulates sphingosine 1-phosphate-mediated migration of human lung endothelial cells through activation of phospholipase D2, protein kinase C-zeta, and Rac1.

Authors:  Irina Gorshkova; Donghong He; Evgeny Berdyshev; Peter Usatuyk; Michael Burns; Satish Kalari; Yutong Zhao; Srikanth Pendyala; Joe G N Garcia; Nigel J Pyne; David N Brindley; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2008-02-22       Impact factor: 5.157

Review 9.  The Dynamics of Apoptotic Cell Clearance.

Authors:  Michael R Elliott; Kodi S Ravichandran
Journal:  Dev Cell       Date:  2016-07-25       Impact factor: 12.270

10.  Sphingosine-1-phosphate effects on the inner wall of Schlemm's canal and outflow facility in perfused human eyes.

Authors:  W Daniel Stamer; A Thomas Read; Grant M Sumida; C Ross Ethier
Journal:  Exp Eye Res       Date:  2009-08-27       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.